Related Experiment Video

Updated: Jun 8, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

Treating mixed hyperlipidemia and the atherogenic lipid phenotype for prevention of cardiovascular events

Melvyn Rubenfire1, Robert D Brook, Robert S Rosenson

  • 1Division of Cardiovascular Medicine, Department of Internal Medicine, University of Michigan, Ann Arbor, Mich 48106, USA. mrubenfi@umich.edu

The American Journal of Medicine
|October 6, 2010
PubMed

Insights

Statins are effective for cardiovascular disease, but residual risk remains. Combination therapy with niacin or omega-3 fatty acids can improve outcomes for patients with atherogenic lipid phenotypes.

Area of Science:

  • Cardiovascular Medicine
  • Pharmacology
  • Lipidology

Background:

  • Statins are primary therapy for reducing cardiovascular events and mortality in coronary disease patients.
  • A significant residual risk of cardiovascular events persists, especially in individuals with atherogenic lipid phenotypes (low HDL, high non-HDL cholesterol).
  • Current evidence suggests combination therapy may be beneficial, though large outcome trials are pending.

Purpose of the Study:

  • To review the evidence for combination therapies to supplement statin treatment in managing dyslipidemia and residual cardiovascular risk.
  • To provide guidance on the optimal sequencing of lipid-lowering agents when statins alone are insufficient.

Main Methods:

  • Review of existing clinical evidence and outcome trial data regarding statin therapy and adjunct lipid-lowering agents.
  • Analysis of therapeutic options including niacin, fibrates, and omega-3 fatty acids for combination with statins.
  • Consideration of treatment strategies based on lipid profiles, particularly the atherogenic lipid phenotype.

Main Results:

  • Maximally tolerated effective doses of potent statins should be the first priority after lifestyle changes.
  • Niacin is supported by evidence as a preferred second agent to add to statin therapy.
  • High-dose omega-3 fatty acids may be considered as an initial add-on therapy in certain cases.
  • Statin-fibrate combination is suggested as second-line therapy pending further safety and efficacy data.

Conclusions:

  • Combination therapy offers a viable strategy to address residual cardiovascular risk in patients with suboptimal lipid profiles despite statin use.
  • Niacin and omega-3 fatty acids represent key options for enhancing statin therapy, with specific indications and sequencing considerations.
  • Further research is needed to establish the long-term safety and efficacy of certain statin combinations, like statin-fibrate.

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...